Abraxis (ABII)

[NYBob]

Abraxane was approved in the United States* in January 2005 and is now approved in Canada for the treatment of metastatic breast cancer.
FDA approval was based on pivotal phase III data that
validated its use in the clinical setting.

* ABRAXANE is a prescription medicine used to treat breast cancer that has spread to other parts of the body after treatment with certain other medicines has not worked.

ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

http://www.abraxisoncology.com/

God Bless